(M36*) Systemic disorders of connective tissue in diseases classified elsewhere

More details coming soon

Icon
NaN% mortality rate associated with the disease systemic disorders of connective tissue in diseases classified elsewhere

Diagnosis systemic disorders of connective tissue in diseases classified elsewhere is diagnosed Prevalent in Women Only

0

Men receive the diagnosis systemic disorders of connective tissue in diseases classified elsewhere

0 (No mortality)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
0

Women receive the diagnosis systemic disorders of connective tissue in diseases classified elsewhere

0 (No mortality)

Died from this diagnosis.

Risk Group for the Disease systemic disorders of connective tissue in diseases classified elsewhere - Men and Women aged 0

Icon
No Cases of the Disease Systemic disorders of connective tissue in diseases classified elsewhere identified in Men
Icon
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-95+
Icon
No Cases of the Disease Systemic disorders of connective tissue in diseases classified elsewhere identified in Men

Disease Features systemic disorders of connective tissue in diseases classified elsewhere

Icon
Absence or low individual and public risk
Icon

Systemic disorders of connective tissue in diseases classified elsewhere - what does this mean

Systemic disorders of connective tissue in diseases classified elsewhere are caused by an abnormal immune response that results in inflammation and damage to the connective tissue, which can affect the skin, joints, and internal organs. this can be caused by an infection, autoimmune disorder, or genetic disorder.

What happens during the disease - systemic disorders of connective tissue in diseases classified elsewhere

Systemic disorders of connective tissue in diseases classified elsewhere results from a systemic inflammatory response to an underlying infection or autoimmune disease. this inflammation leads to damage of the connective tissue, which can lead to further tissue damage, organ dysfunction, and further systemic inflammation. the underlying cause of the inflammation must be identified and treated to prevent further damage to the connective tissue.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Laboratory tests (e.g. complete blood count, erythrocyte sedimentation rate, C-reactive protein, antinuclear antibody, rheumatoid factor, complement levels)
  • Imaging tests (e.g. X-rays, CT scans, MRI scans)
  • Genetic testing
  • Tissue biopsy
  • Pulmonary function tests
  • Electrocardiogram (ECG)
  • Cardiac stress test

Treatment and Medical Assistance

Main goal of the treatment: To reduce inflammation and restore normal function of the connective tissue.
  • Administer medication to reduce inflammation.
  • Provide physical therapy to increase flexibility and range of motion.
  • Encourage lifestyle modifications such as diet and exercise.
  • Monitor the patient's symptoms and adjust medication as needed.
  • Educate the patient on how to manage their condition.
  • Refer the patient to a specialist as needed.
Icon
No Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Systemic disorders of connective tissue in diseases classified elsewhere - Prevention

The best way to prevent systemic disorders of connective tissue in diseases classified elsewhere is to maintain a healthy lifestyle, including a balanced diet, regular exercise, and avoiding smoking and excessive alcohol consumption. additionally, it is important to get regular checkups and screenings to detect any potential issues early on.

Specified forms of the disease

(D69.0) Allergic purpura
(D69.1) Qualitative platelet defects
(D69.2) Other nonthrombocytopenic purpura
(D69.3) Idiopathic thrombocytopenic purpura
(D69.4) Other primary thrombocytopenia
(D69.5) Secondary thrombocytopenia
(D69.6) Thrombocytopenia, unspecified
(D69.8) Other specified haemorrhagic conditions
(D69.9) Haemorrhagic condition, unspecified